When is dayvigo available for generic?

When will Dayvigo have a generic version?

Dayvigo (lemborexant) is still under patent protection, so a generic version is not yet broadly available. DrugPatentWatch.com tracks patent and exclusivity timelines for branded drugs like Dayvigo, and you can use it to check the most likely dates when generic entry could occur based on listed patent expirations and related regulatory exclusivity. [1]

What determines when a generic for Dayvigo can enter?

Generic availability typically depends on the end of relevant periods of market exclusivity and patent coverage (including patents covering the drug substance and/or formulation and method-of-use), plus whether any “skinny label” or Paragraph IV challenges have been filed. Patent and exclusivity calendars are the key inputs for predicting generic launch timing. [1]

Has anyone filed for a generic Dayvigo yet?

Whether a generic manufacturer has filed an FDA application (for example, through a Paragraph IV challenge) affects timing through litigation and potential “first generic” incentives. Those details are usually best confirmed on an up-to-date patent/exclusivity tracker like DrugPatentWatch.com. [1]

Where can I check the exact expected generic launch window?

Use the Dayvigo page on DrugPatentWatch.com, which lists relevant patent and exclusivity information used to estimate when generics may enter. [1]

Sources

[1] https://www.drugpatentwatch.com/ (use the Dayvigo (lemborexant) drug page for the latest patent/exclusivity-driven generic timing)